Differentiated neuroblastoma cells provide a highly efficient model for studies of productive Varicella-zoster virus infection of neuronal cells

Journal of Virology

Volumn 85, Issue 16, 2011, Pages 8436-8442

  Christensen, Jenna ^a   Steain, Megan ^a,b   Slobedman, Barry ^a,b   Abendroth, Allison ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; RETINOIC ACID; SYNAPTOPHYSIN; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL CLONE; CELL CULTURE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC IDENTIFICATION; HERPES ZOSTER; HUMAN; HUMAN CELL; NERVE CELL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VARICELLA ZOSTER VIRUS; VIRAL TROPISM; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 3;

EID: 79961194365     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00515-11     Document Type: Article

References (56)

1. Ambagala, A. P., T. Krogmann, J. Qin, L. Pesnicak, and J. I. Cohen. 2010. A varicella-zoster virus mutant impaired for latency in rodents, but not impaired for replication in cell culture. Virology 399:194-200.
2. Arvin, A. 2001. Varicella-zoster virus, p. 2731-2767. In D. M. Knipe and P. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Arvin, A. M. 2006. Investigations of the pathogenesis of varicella zoster virus infection in the SCIDhu mouse model. Herpes 13:75-80.
4. Biedler, J. L., L. Helson, and B. A. Spengler. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:2643-2652.
5. Chen, J. J., A. A. Gershon, Z. S. Li, O. Lungu, and M. D. Gershon. 2003. Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J. Med. Virol. 70(Suppl. 1):S71-S78.
6. Cheung, Y. T., et al. 2009. Effects of all-trans-retinoic acid on human SHSY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30:127-135.
7. Chouliaras, G., V. Spoulou, M. Quinlivan, J. Breuer, and M. Theodoridou. 2010. Vaccine-associated herpes zoster ophthalmicus and encephalitis in an immunocompetent child. Pediatrics 125:e969-e972. http://pediatrics.aappublications.org/content/125/4/e969.full.html.
8. Cohen, J., and S. Straus. 2001. Varicella-zoster virus and its replication, p. 2707-2730. In D. M. Knipe and P. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
9. Cohen, J. I. 2010. Rodent models of varicella-zoster virus neurotropism. Curr. Top. Microbiol. Immunol. 342:277-289.
10. Cohen, J. I., E. Cox, L. Pesnicak, S. Srinivas, and T. Krogmann. 2004. The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J. Virol. 78:11833-11840.
11. Cohen, J. I., T. Krogmann, S. Bontems, C. Sadzot-Delvaux, and L. Pesnicak. 2005. Regions of the varicella-zoster virus open reading frame 63 latencyassociated protein important for replication in vitro are also critical for efficient establishment of latency. J. Virol. 79:5069-5077.
12. Cohen, J. I., T. Krogmann, L. Pesnicak, and M. A. Ali. 2007. Absence or overexpression of the varicella-zoster virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent model. J. Virol. 81:1586-1591.
13. Cohen, J. I., T. Krogmann, J. P. Ross, L. Pesnicak, and E. A. Prikhod'ko. 2005. Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency. J. Virol. 79:6969-6975.
14. Cohrs, R. J., M. Barbour, and D. H. Gilden. 1996. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol. 70:2789-2796.
15. Edson, C. M., et al. 1985. Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material. Virology 145:62-71.
16. Encinas, M., et al. 2000. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75: 991-1003.
17. Galea, S. A., et al. 2008. The safety profile of varicella vaccine: a 10-year review. J. Infect. Dis. 197(Suppl. 2):S165-S169.
18. Gilden, D. H., B. K. Kleinschmidt-DeMasters, J. J. LaGuardia, R. Mahalingam, and R. J. Cohrs. 2000. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342:635-645.
19. Gilden, D. H., Y. Rozenman, R. Murray, M. Devlin, and A. Vafai. 1987. Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann. Neurol. 22:377-380.
20. Goulleret, N., E. Mauvisseau, M. Essevaz-Roulet, M. Quinlivan, and J. Breuer. 2010. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). Vaccine 28:5878-5882.
21. Gowrishankar, K., et al. 2007. Productive varicella-zoster virus infection of cultured intact human ganglia. J. Virol. 81:6752-6756.
22. Han, J. Y., D. C. Hanson, and S. S. Way. 2011. Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child. Pediatr. Infect. Dis. J. 30:266-268.
23. Honess, R. W., and B. Roizman. 1974. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:8-19.
24. Hood, C., et al. 2006. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. J. Virol. 80:1025-1031.
25. Hood, C., A. L. Cunningham, B. Slobedman, R. A. Boadle, and A. Abendroth. 2003. Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response. J. Virol. 77:12852-12864.
26. Hyman, R. W., J. R. Ecker, and R. B. Tenser. 1983. Varicella-zoster virus RNA in human trigeminal ganglia. Lancet ii:814-816.
27. Iyer, S., M. K. Mittal, and R. L. Hodinka. 2009. Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child. Ann. Emerg. Med. 53:792-795.
28. Kennedy, P. G., E. Grinfeld, and J. E. Bell. 2000. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J. Virol. 74: 11893-11898.
29. Kennedy, P. G., E. Grinfeld, S. Bontems, and C. Sadzot-Delvaux. 2001. Varicella-zoster virus gene expression in latently infected rat dorsal root ganglia. Virology 289:218-223.
30. Kennedy, P. G., E. Grinfeld, and J. W. Gow. 1999. Latent varicella-zoster virus in human dorsal root ganglia. Virology 258:451-454.
31. Kennedy, P. G., E. Grinfeld, and J. W. Gow. 1998. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc. Natl. Acad. Sci. U. S. A. 95:4658-4662.
32. Kinchington, P. R., and S. E. Turse. 1998. Regulated nuclear localization of the varicella-zoster virus major regulatory protein, IE62. J. Infect. Dis. 178(Suppl. 1):S16-S21.
33. La Monica, N., and V. R. Racaniello. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 63:2357-2360.
34. Levin, M. J., G. Y. Cai, M. D. Manchak, and L. I. Pizer. 2003. Varicellazoster virus DNA in cells isolated from human trigeminal ganglia. J. Virol. 77:6979-6987.
35. Lungu, O., C. A. Panagiotidis, P. W. Annunziato, A. A. Gershon, and S. J. Silverstein. 1998. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. U. S. A. 95:7080-7085.
36. Luo, M. H., and E. A. Fortunato. 2007. Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells. J. Virol. 81:10424-10436.
37. Mueller, N. H., D. H. Gilden, R. J. Cohrs, R. Mahalingam, and M. A. Nagel. 2008. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol. Clin. 26:675-697.
38. Myers, M. G., and B. L. Connelly. 1992. Animal models of varicella. J. Infect. Dis. 166(Suppl. 1):S48-S50.
39. Reichelt, M., J. Brady, and A. M. Arvin. 2009. The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J. Virol. 83: 3904-3918.
40. Sadzot-Delvaux, C., S. Debrus, A. Nikkels, J. Piette, and B. Rentier. 1995. Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology 45:S18-S20.
41. Sadzot-Delvaux, C., et al. 1990. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J. Neurosci. Res. 26:83-89.
42. Sato, H., L. Pesnicak, and J. I. Cohen. 2003. Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency. J. Med. Virol. 70(Suppl. 1):S79-S81.
43. Sato, H., L. Pesnicak, and J. I. Cohen. 2002. Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J. Virol. 76:3575-3578.
44. Sato, H., L. Pesnicak, and J. I. Cohen. 2003. Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency. J. Virol. 77:11180-11185.
45. Shastry, P., A. Basu, and M. S. Rajadhyaksha. 2001. Neuroblastoma cell lines-a versatile in vitro model in neurobiology. Int. J. Neurosci. 108:109-126.
46. Slack, R., B. Lach, A. Gregor, H. Al-Mazidi, and P. Proulx. 1992. Retinoic acid- and staurosporine-induced bidirectional differentiation of human neuroblastoma cell lines. Exp. Cell Res. 202:17-27.
47. Steain, M., K. Gowrishankar, M. Rodriguez, B. Slobedman, and A. Abendroth. 2011. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection. J. Virol. 85:626-631.
48. Steain, M., B. Slobedman, and A. Abendroth. 2010. Experimental models to study varicella-zoster virus infection of neurons. Curr. Top. Microbiol. Immunol. 342:211-228.
49. Steiner, I., P. G. Kennedy, and A. R. Pachner. 2007. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 6:1015-1028.
50. Sun, Z., et al. 2010. Establishment of a cell model system of herpes simplex virus type II latent infection and reactivation in SH-SY5Y cells. Wei Sheng Wu Xue Bao 50:98-106. (In Chinese with English summary.)
51. Weller, T. H. 1953. Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster. Proc. Soc. Exp. Biol. Med. 83:340-346.
52. Xia, D., et al. 2003. Varicella-zoster virus open reading frame 21, which is expressed during latency, is essential for virus replication but dispensable for establishment of latency. J. Virol. 77:1211-1218.
53. Zerboni, L., et al. 2011. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis. J. Virol. 85:98-111.
54. Zerboni, L., C. C. Ku, C. D. Jones, J. L. Zehnder, and A. M. Arvin. 2005. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:6490-6495.
55. Zerboni, L., M. Reichelt, and A. Arvin. 2010. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts. Curr. Top. Microbiol. Immunol. 342:255-276.
56. Zerboni, L., et al. 2007. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. Proc. Natl. Acad. Sci. U. S. A. 104:14086-14091.